Navigation Links
Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films
Date:9/16/2008

BETHLEHEM, Pa., Sept. 16 /PRNewswire/ -- Particle Sciences, Inc. announces the issuing of its patent (US7,419,527) on a unique system for increasing the density of sintered metal products. The technology allows for the processing of powdered metals in a way that decreases needed injection forces, decreases lubricant requirements and results in structurally superior end-products. It is based on a proprietary coating applied to the powders prior to sintering. "This could both increase the quality of the finished product and substantially decrease the environmental impact of the manufacturing process," says Garry Gwozdz, Director of Formulation and one of the inventors at Particle Sciences. Particle Sciences is a CRO primarily focused on pharmaceutical applications. This technology is an offshoot of some of their nano-particle work involving a unique drug delivery approach. "This is pretty far from our core business so we intend to out-license the technology. It could dovetail nicely with an earlier technology we developed and patented (US6,045,650) involving the coating of surfaces with metal oxides, titanium dioxide for instance. The '527 provides for sintered metal products with improved physical characteristics and lowered carbon footprint. The '650 technology allows for the application of low cost carefully controlled, even printable, metal oxide surface coatings. Both of these technologies came out of our efforts in the pharmaceutical arena but clearly have broader applicability so we intend to partner with companies that can better take advantage of the opportunities," says Dr. Mark Mitchnick, CEO of Particle Sciences. For more information, visit http://www.particlesciences.com.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.

Contact:

Maureen Cochran

mcochran@particlesciences.com


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Particle Sciences Develops Zero-Order-Release Combination Device Technology
2. New disease-fighting nanoparticles look like miniature pastries
3. Nanoparticles + light = dead tumor cells
4. Using magenetic nanoparticles to combat cancer
5. Nanoparticle Stops Cancer From Spreading
6. Waves, particles and medicine in Houston
7. Smart bomb nanoparticle strategy impacts metastasis
8. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
9. Nanoparticles aid bone growth
10. Magnetic nanoparticles: Suitable for cancer therapy?
11. Brown chemists create cancer-detecting nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: